Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Postcoital Bleeding Evaluation and Management

Initial Assessment and Diagnostic Approach

  • Women under 25 years or those with new/multiple partners are at higher risk for sexually transmitted infections causing cervicitis, according to the Centers for Disease Control and Prevention (CDC) 1, 2
  • The evaluation should focus on characteristics of bleeding, including timing, volume, and associated symptoms (pain, discharge, dyspareunia), as recommended by the CDC 1

Diagnostic Testing and Treatment

  • Laboratory evaluation should include STI testing, such as NAAT testing for Chlamydia trachomatis and Neisseria gonorrhoeae on cervical or urine specimens, as recommended by the CDC 1, 2
  • Wet mount should be performed to assess for >10 WBCs per high-power field (suggests cervicitis) and evaluate for trichomoniasis or bacterial vaginosis, according to the CDC 1, 2
  • Presumptive treatment for cervicitis is indicated for women at high risk (age <25, new/multiple partners) with Azithromycin 1 g orally single dose OR Doxycycline 100 mg orally twice daily for 7 days, as recommended by the CDC 1, 2
  • Partner treatment is essential to prevent reinfection with STIs, as recommended by the CDC 1, 2

Management Approach

  • A speculum examination is mandatory and should assess for cervicitis, cervical lesions, and vaginal trauma, according to the CDC 1, 2
  • The management algorithm should include performing a speculum examination, initiating presumptive STI treatment for high-risk women, and referring to gynecology if examination is normal but bleeding persists, as recommended by the CDC 1, 2

Postcoital Bleeding Evaluation and Management

Introduction to Postcoital Bleeding

  • The probability of cervical cancer in women with postcoital bleeding ranges from 1 in 44,000 for women aged 20-24 to 1 in 2,400 for women aged 45-54, according to the British Medical Journal 3
  • Visible ulcerating or fungating cervical lesion on examination mandates urgent referral for suspected malignancy, as recommended by the British Medical Journal 3
  • Younger age (20-24 years) has substantially lower cancer probability, as reported by the British Medical Journal 3
  • Unscheduled PAP smears are NOT recommended outside the regular screening program, as stated by the British Medical Journal 3
  • Do not perform unscheduled PAP smears as part of postcoital bleeding evaluation—they are not recommended and delay appropriate management, according to the British Medical Journal 3
  • Do not miss frank cervical cancer by failing to perform speculum examination—all women require direct visualization, as emphasized by the British Medical Journal 3
  • Do not delay referral when malignancy is suspected based on examination findings, as advised by the British Medical Journal 3